Laurion Capital Management LP Catalent, Inc. Transaction History

Laurion Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $41.8 Million - $68.3 Million	919,854 New	919,854 $60.4 Million
Q1 2021 May 14, 2021	SELL	$101.51 - $125.27 $219,769 - $271,209	-2,165 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $185,930 - $228,104	2,165 New	2,165 $225,000
Q3 2020 Nov 13, 2020	SELL	$72.74 - $92.5 $3.26 Million - $4.15 Million	-44,852 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $2.15 Million - $3.55 Million	44,852 New	44,852 $3.29 Million
Q1 2019 May 08, 2019	SELL	$29.84 - $43.92 $275,124 - $404,942	-9,220 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$29.95 - $46.34 $276,139 - $427,254	9,220 New	9,220 $287,000
Q4 2017 Feb 13, 2018	SELL	$37.27 - $43.02 $190,077 - $219,402	-5,100 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$33.75 - $41.67 $172,125 - $212,517	5,100	5,100 $204,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.